Therapeutic Oligonucleotides Overview
Therapeutics oligonucleotides (oligos) have emerged as an area of particular interest and promise in biopharmaceutical development because of their potential to treat a wide range of diseases.These oligos can range in size, sequence complexity, and overall modifications.Synthetic oligonucleotide therapeutics, such as antisense oligonucleotides (ASOs) and small interfering RNAs (si-RNAs), require thorough analysis to establish intended purity and quality.
必威体育登录手机Agilent Solutions
Advance Your Lead Oligonucleotide from Discovery to Market - Invest in a proven superior solution, services provider offering multi-application capabilities with a diverse compliant ready portfolio solution and world-class innovation to enable cost-effective manufacturing of commercial-scale quantities of synthetic oligonucleotides.
必威体育登录手机AGILENT OLIGONUCLEOTIDES END-TO-END WORKFLOW SOLUTIONS
Oligo Purity Analysis | Oligo Target Plus Impurity Analysis | Oligo Sequence Confirmation | Oligo Purification | Oligo Raw Material Identification | Trace Elemental Impurities | Residual Solvent Analysis | Oligo API Manufacturing
必威体育登录手机AGILENT OLIGONUCLEOTIDES WORKFLOW PRODUCTS
-
-
Consumables and Services Solutions for Oligos
AdvanceBio Columns|Preparative LC Columns|PLRP-S Columns|PL-SAX Columns|必威体育登录手机Agilent Flexible Spend Plan|必威体育登录手机Agilent Certified Pre-Owned Instruments|Alternative Buying Model
-
